COVID-19 Booster Dose Is Safe, Elicits Robust Immune Responses In Children Aged Six Months To 11 Years, Study Finds

Infectious Disease Advisor (9/24, Basilio) reports “an mRNA-1273 booster dose was safe and elicited robust immune responses against SARS-CoV-2 infection in children aged 6 months to 5 years and” 6 “to 11 years, according to study results.” Researchers found that “among the younger cohort, solicited local and systemic adverse reactions were reported in 49.0% and 63.4% of patients, respectively.” Meanwhile, “among the older cohort, solicited local and systemic adverse reactions were reported in 90.30% and 61.3% of patients, respectively.” The findings were published in Clinical Infectious Diseases.